Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA)

NCT03912415 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

BIOLOGICAL: BCD-100
BIOLOGICAL: Bevacizumab
DRUG: Paclitaxel
DRUG: Cisplatin (or Carboplatin)
OTHER: Placebo

Sponsor

Biocad